Mersana Secures $4,000,000 New Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    840 Memorial Drive Cambridge, MA 02139
  • Company Description
    Mersana Therapeutics, Inc. (formerly Nanopharma Corp.) is focused on developing novel oncology agents based on Fleximer, a stealth material that enhances the pharmacokinetics and safety of drugs.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Fidelity BioSciences

Trending on Xconomy